The Bob Harrington Show

 
 

The Bob Harrington Show is a podcast series of thoughtful interviews and discussions on topics at the core of cardiology and the practice of medicine. Subscribe on Apple Podcasts, Spotify, or your preferred podcast provider.

  • For America First, Invest in Science and the NIH   Panel discussion of a Presidential Advisory from the American Heart Association that outlines the importance of funding for scientific research and the need for a robust National Institutes of Health.
  • Cardiology 2024 Highlights and Predictions for 2025   Drs Harrington and Gibson review their picks for the top cardiology trials of 2024 and look ahead to 2025, particularly what health topics may be prioritized by the new administration.
  • Does STEMI Need a Rebrand to ‘Occlusion MI’?   A review paper prompted a discussion among cardiologists Bob Harrington, Manesh Patel, and Michael Gibson on whether the ST-segment elevation myocardial infarction paradigm needs an update.
  • CVD 2050: No, GLP-1s Won't Save the Day   Cardiologists Bob Harrington and Dhruv Kazi discuss the projected burden of cardiovascular disease in 2050, why it's not sustainable, and what can be done to prevent it.
  • From Fact to Fiction: Medical Journalist-Turned-Author   Dr Bob Harrington interviews journalist Shelley Wood about her new book, "The Leap Year Gene of Kit McKinley," her creative process, and the difference between medical journalism and writing fiction.
  • Private Equity in Medicine: Cardiology in the Crosshairs   Medical practices are increasingly being acquired by private equity. Bob Harrington discusses why and what the ramifications are with the authors and editorialist of a research paper on the private equity landscape in cardiology vs other specialties.
  • Food Is Not Medicine but Maybe It's Healthcare   Bob Harrington and Mitch Elkind discuss whether food is medicine, as well as the American Heart Association initiative to study the best way to use food to treat cardiovascular disease.
  • Coronary Artery Disease: The New Big C   Bob Harrington interviews fellow cardiologist Mike McConnell about his new book Fight Heart Disease Like Cancer and the need to model heart disease prevention and treatment after cancer.
  • Correlation Is Not Causation, Wink, Is Not Good Enough   Cardiology researchers Bob Harrington and Bobby Yeh discuss how to do better observational research and the controversial notion of making causal inferences from such data.
  • Publish or Perish and Incentives for Quantity over Quality   Bob Harrington, Erin Michos, and Brahmajee Nallamothu discuss how the publish or perish culture can lead to sloppy research and the need for alternative models to measure success in academic medicine.
  • Topics Cardiologists Love to Hate: MOC and AI   Bob Harrington and Mike Gibson discuss two of the hottest topics in cardiology and medicine for 2023: a proposed alternative to the maintenance of certification process, and artificial intelligence.
  • The Top Cardiology Trials of 2023   For this year's review, Bob Harrington and Mike Gibson revisit the major cardiology conferences -- from ACC in New Orleans to AHA in Philly.
  • SCD in Athletes: Lessons From High-Profile Cases   Bob Harrington and Manesh Patel discuss sudden cardiac death in athletes, and how cases such as Bronny James' and Damar Hamlin's highlight the importance of the chain of survival.
  • From Physician to Patient to Reinventing Medicine   Bob Harrington interviews Jag Singh about the COVID journey that led to his book, "Future Care: Sensors, Artificial Intelligence, and the Reinvention of Medicine."
  • AI and Machine Learning in Healthcare for the Clueless   Robert Harrington and Jenine John, a cardiologist and machine-learning research fellow, discuss what you need to know about AI and machine learning in healthcare and where to find some helpful resources.
  • The Career Pivot: Leaving Clinical Medicine   Bob Harrington talks to two former colleagues who made a mid- and senior-career switch to pharma and digital tech, respectively. How did they make this decision and what advice do they have for others?
  • Top Cardiology Trials of 2022   Trials on heart failure, hypertension and lipid-lowering drugs, and the evolution of antithrombin and antiplatelet therapy are discussed in part 2 of cardiologists Bob Harrington and Mike Gibson's annual review.
  • 2022 in Review Through a Cardiology Lens   In part 1 of their annual review, cardiologists Bob Harrington and Mike Gibson discuss in-person meetings, wearables and AI, COVID lessons for medical research, and the growth of RCTs from China.
  • What Do We Know About Long COVID: A Cardiovascular Focus   Drs Bob Harrington and Betty Raman discuss the cardiovascular impact and long-term sequelae of COVID-19, the potential biology behind multisystem effects, and ongoing research.
  • Do Older vs Younger Docs Treat AF Differently?   Do cardiologists from the AFFIRM generation treat AF less aggressively than the EAST-AFNET generation? Bob Harrington and Jonathan Piccini discuss this and upcoming trials on atrial fibrillation.